Zevra Q2 2026 Reacts on MIPLYFFA Sales
Zevra Therapeutics reported net revenue of $39.7 million for Q2 2026, driven by a 53% increase largely from MIPLYFFA sales.
View filing at SEC.gov →1 most recent filing and news item mentioning ZVRA. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ZVRA/news?limit=20"
Pull ZVRA filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayZevra Therapeutics reported net revenue of $39.7 million for Q2 2026, driven by a 53% increase largely from MIPLYFFA sales.
View filing at SEC.gov →